Mechanisms of ATP release, the enabling step in purinergic dynamics

Cellular Physiology and Biochemistry

Volumn 28, Issue 6, 2011, Pages 1135-1144

  Li, Ang ^a,b   Banerjee, Juni ^a   Leung, Chi Ting ^a   Peterson Yantorno, Kim ^a   Stamer, W Daniel ^c   Civan, Mortimer M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c DUKE UNIVERSITY   (United States)

Author keywords

Actin cytoskeleton; Ciliary epithelium; Connexin hemichannels; Intraocular pressure; Pannexin 1 hemichannels; Trabecular meshwork; Vesicular release

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; BAFILOMYCIN A1; CHLORIDE CHANNEL; CONNEXIN 32; DITHIOTHREITOL; FIBROBLAST GROWTH FACTOR; GAP JUNCTION PROTEIN; GELATINASE B; GLYCOPROTEIN P; IONOMYCIN; LUCIFERIN; MATRIX METALLOPROTEINASE; PURINERGIC P2 RECEPTOR; STROPHANTHIDIN;

AQUEOUS HUMOR; CALCIUM CELL LEVEL; CELL SWELLING; CILIATED EPITHELIUM; CYTOLYSIS; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; INTRAOCULAR PRESSURE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCHLEMM CANAL; TRABECULAR MESHWORK;

EID: 83755206958     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335865     Document Type: Review

References (77)

1. Quigley HA: Number of people with glaucoma worldwide. Br J Ophthalmol 1996;80:389-393. (Pubitemid 26158268)
2. Collaborative Normal-Tension Glaucoma Study Group: The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126:498-505.
3. Collaborative Normal-Tension Glaucoma Study Group: Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-497.
4. The AGIS investigators: The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-440.
5. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO: The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-713; discussion 829-730. (Pubitemid 34620348)
6. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E: Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56. (Pubitemid 36401765)
7. Higginbotham EJ, Gordon MO, Beiser JA, Drake MV, Bennett GR, Wilson MR, Kass MA: The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch Ophthalmol 2004;122:813-820. (Pubitemid 38736239)
8. Pang IH, Clark AF: Outflow Signaling Mechanisms and New Therapeutic Strategies for the Control of Intraocular Pressure; in Civan MM (ed): The Eye's Aqueous Humor, Second Edition. San Diego, Elsevier, 2008, pp 429-469.
9. Mitchell CH, Peterson-Yantorno K, Carré DA, McGlinn AM, Coca-Prados M, Stone RA, Civan MM: A3 adenosine receptors regulate Cl-channels of nonpigmented ciliary epithelial cells. Am J Physiol 1999;276:C659-666. (Pubitemid 29157382)
10. Carré DA, Mitchell CH, Peterson-Yantorno K, Coca-Prados M, Civan MM: Similarity of A(3)-adenosine and swellingactivated Cl(-) channels in nonpigmented ciliary epithelial cells. Am J Physiol Cell Physiol 2000;279:C440-451.
11. Avila MY, Stone RA, Civan MM: A(1)-, A(2A)-and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse. Br J Pharmacol 2001;134:241-245. (Pubitemid 32989120)
12. Shearer TW, Crosson CE: Adenosine A1 receptor modulation of MMP-2 secretion by trabecular meshwork cells. Invest Ophthalmol Vis Sci 2002;43:3016-3020. (Pubitemid 34977054)
13. Tian B, Gabelt BT, Crosson CE, Kaufman PL: Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys. Exp Eye Res 1997;64:979-989. (Pubitemid 27314773)
14. Crosson CE, Sloan CF, Yates PW: Modulation of conventional outflow facility by the adenosine A1 agonist N6-cyclohexyladenosine. Invest Ophthalmol Vis Sci 2005;46:3795-3799. (Pubitemid 44264688)
15. Crosson CE: Adenosine receptor activation modulates intraocular pressure in rabbits. J Pharmacol Exp Ther 1995;273:320-326.
16. Crosson CE, Gray T: Characterization of ocular hypertension induced by adenosine agonists. Invest Ophthalmol Vis Sci 1996;37:1833-1839. (Pubitemid 26265033)
17. Mitchell CH, Carré DA, McGlinn AM, Stone RA, Civan MM: A release mechanism for stored ATP in ocular ciliary epithelial cells. Proc Natl Acad Sci USA 1998;95:7174-7178. (Pubitemid 28278126)
18. Li A, Leung CT, Peterson-Yantorno K, Stamer WD, Mitchell CH, Civan MM: Mechanisms of ATP release by human trabecular meshwork cells, the enabling step in purinergic regulation of aqueous humor outflow. J Cell Physiol 2012;227:172-182.
19. Li A, Leung CT, Peterson-Yantorno K, Mitchell CH, Civan MM: Pathways for ATP release by bovine ciliary epithelial cells, the initial step in purinergic regulation of aqueous humor inflow. Am J Physiol Cell Physiol 2010;299:C1308-1317.
20. Li A, Leung CT, Peterson-Yantorno K, Stamer WD, Civan MM: Cytoskeletal dependence of adenosine triphosphate release by human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2011;52:7996-8005.
21. Civan MM: Formation of the Aqueous Humor: Transport Components and their Integration. in Civan MM (ed): The Eye's Aqueous Humor, Second Edition. San Diego, Elsevier, 2008, pp 2-45.
22. Stamer WD, Baetz NW, Yool AJ: Ocular Aquaporins and Aqueous Humor Dynamics. in Civan MM (ed): The Eye's Aqueous Humor, Second Edition. San Diego, Elsevier, 2008, pp 47-70.
23. Do C-W, Civan MM: Basis of chloride transport in ciliary epithelium. J. Membr Biol 2004;200:1-13. (Pubitemid 39193200)
24. Do CW, Peterson-Yantorno K, Civan MM: Swelling-activated Cl-channels support Cl-secretion by bovine ciliary epithelium. Invest Ophthalmol Vis Sci 2006;47:2576-2582. (Pubitemid 351639844)
25. Wang L, Chen L, Jacob TJ: The role of ClC-3 in volume-activated chloride currents and volume regulation in bovine epithelial cells demonstrated by antisense inhibition. J Physiol 2000;524:63-75. (Pubitemid 30195306)
26. Vessey JP, Shi C, Jollimore CA, Stevens KT, Coca-Prados M, Barnes S, Kelly ME: Hyposmotic activation of ICl,swell in rabbit nonpigmented ciliary epithelial cells involves increased ClC-3 trafficking to the plasma membrane. Biochem Cell Biol 2004;82:708-718. (Pubitemid 40486149)
27. Do CW, Lu W, Mitchell CH, Civan MM: Inhibition of swelling-activated Clcurrents by functional anti-ClC-3 antibody in native bovine non-pigmented ciliary epithelial cells. Invest Ophthalmol Vis Sci 2005;46:948-955. (Pubitemid 41321032)
28. Chen L, Wang L, Jacob TJ: Association of intrinsic pICln with volume-activated Cl-current and volume regulation in a native epithelial cell. Am J Physiol 1999;276:C182-192. (Pubitemid 29063581)
29. Hermoso M, Satterwhite CM, Andrade YN, Hidalgo J, Wilson SM, Horowitz B, Hume JR: ClC-3 is a fundamental molecular component of volumesensitive outwardly rectifying Clchannels and volume regulation in HeLa cells and Xenopus laevis oocytes. J Biol Chem 2002;277:40066-40074. (Pubitemid 35190996)
30. Jentsch TJ, Stein V, Weinreich F, Zdebik AA: Molecular structure and physiological function of chloride channels. Physiol Rev 2002;82:503-568. (Pubitemid 34654460)
31. Clapham DE: The list of potential volume-sensitive chloride currents continues to swell (and shrink). J Gen Physiol 1998;111:623-624. (Pubitemid 28232185)
32. Strange K: Molecular identity of the outwardly rectifying, swelling-activated anion channel: time to reevaluate pICln. J Gen Physiol 1998;111:617-622. (Pubitemid 28232184)
33. Fürst J, Bottà G, Saino S, Dopinto S, Gandini R, Dossena S, Vezzoli V, Rodighiero S, Bazzini C, Garavaglia ML, Meyer G, Jakab M, Ritter M, Wappl-Kornherr E, Paulmichl M: The ICln interactome. Acta Physiol (Oxf) 2006;187:43-49. (Pubitemid 43828762)
34. Avila MY, Stone RA, Civan MM: Knockout of A(3) adenosine receptors reduces mouse intraocular pressure. Invest Ophthalmol Vis Sci 2002;43:3021-3026. (Pubitemid 34977055)
35. Toris CB, Camras CB: Aqueous Humor Dynamics II: Clinical Studies; in Civan MM (ed): The Eye's Aqueous Humor, Second Edition. San Diego, Elsevier, 2008, pp 231-272.
36. Freddo TF, Johnson M: Aqueous Humor Outflow Resistance; in Civan MM (ed): The Eye's Aqueous Humor, Second Edition. San Diego, Elsevier, 2008, pp 161-192.
37. Bradley JM, Vranka J, Colvis CM, Conger DM, Alexander JP, Fisk AS, Samples JR, Acott TS: Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci 1998;39:2649-2658. (Pubitemid 28558223)
38. Bradley JM, Kelley MJ, Zhu X, Anderssohn AM, Alexander JP, Acott TS: Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest Ophthalmol Vis Sci 2001;42:1505-1513. (Pubitemid 32520742)
39. Husain S, Shearer TW, Crosson CE: Mechanisms linking adenosine A1 receptors and extracellular signalregulated kinase 1/2 activation in human trabecular meshwork cells. J Pharmacol Exp Ther 2007;320:258-265. (Pubitemid 46025742)
40. Yegutkin GG: Nucleotide-and nucleosideconverting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008;1783:673-694.
41. Pang IH, Shade DL, Clark AF, Steely HT, DeSantis L: Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr Eye Res 1994;13:51-63. (Pubitemid 24053155)
42. Sabirov RZ, Okada Y: ATP release via anion channels. Purinergic Signal 2005;1:311-328. (Pubitemid 43023766)
43. Prat AG, Reisin IL, Ausiello DA, Cantiello HF: Cellular ATP release by the cystic fibrosis transmembrane conductance regulator. Am J Physiol 1996;270:C538-545.
44. Schwiebert EM, Egan ME, Hwang TH, Fulmer SB, Allen SS, Cutting GR, Guggino WB: CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 1995;81:1063-1073.
45. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti G, Cantiello HF: The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci USA 1993;90:312-316. (Pubitemid 23010300)
46. Roman RM, Wang Y, Lidofsky SD, Feranchak AP, Lomri N, Scharschmidt BF, Fitz JG: Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume. J Biol Chem 1997;272:21970-21976. (Pubitemid 27382818)
47. Spray DC, Ye ZC, Ransom BR: Functional connexin "hemichannels": A critical appraisal. Glia 2006;54:758-773. (Pubitemid 44629638)
48. Sabirov RZ, Sheiko T, Liu H, Deng D, Okada Y, Craigen WJ: Genetic demonstration that the plasma membrane maxianion channel and voltage-dependent anion channels are unrelated proteins. J Biol Chem 2006;281:1897-1904. (Pubitemid 43845774)
49. Scemes E, Suadicani SO, Dahl G, Spray DC: Connexin and pannexin mediated cell-cell communication. Neuron Glia Biol 2007;3:199-208. (Pubitemid 351594228)
50. Ebihara L, Steiner E: Properties of a nonjunctional current expressed from a rat connexin46 cDNA in Xenopus oocytes. J Gen Physiol 1993;102:59-74. (Pubitemid 23210593)
51. Panchin Y, Kelmanson I, Matz M, Lukyanov K, Usman N, Lukyanov S: A ubiquitous family of putative gap junction molecules. Curr Biol 2000;10:R473-474. (Pubitemid 30466927)
52. Ambrosi C, Gassmann O, Pranskevich JN, Boassa D, Smock A, Wang J, Dahl G, Steinem C, Sosinsky GE: Pannexin1 and Pannexin2 channels show quaternary similarities to connexons and different oligomerization numbers from each other. J Biol Chem 2010;285:24420-24431.
53. Bruzzone R, Barbe MT, Jakob NJ, Monyer H: Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem 2005;92:1033-1043. (Pubitemid 40344294)
54. Bao L, Locovei S, Dahl G: Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett 2004;572:65-68. (Pubitemid 39092514)
55. Ma W, Hui H, Pelegrin P, Surprenant A: Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J Pharmacol Exp Ther 2009;328:409-418.
56. Locovei S, Bao L, Dahl G: Pannexin 1 in erythrocytes: function without a gap. Proc Natl Acad Sci USA 2006;103:7655-7659.
57. Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H: Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci U S A 2003;100:13644-13649. (Pubitemid 37444793)
58. Iwamoto T, Nakamura T, Doyle A, Ishikawa M, de Vega S, Fukumoto S, Yamada Y: Pannexin 3 regulates intracellular ATP/cAMP levels and promotes chondrocyte differentiation. J Biol Chem 2010;285:18948-18958.
59. Bond SR, Lau A, Penuela S, Sampaio AV, Underhill TM, Laird DW, Naus CC: Pannexin 3 is a novel target for Runx2, expressed by osteoblasts and mature growth plate chondrocytes. J Bone Miner Res 2011;26:2911-2922.
60. Khakh BS, North RA: P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006;442:527-532. (Pubitemid 44167906)
61. Pelegrin P, Surprenant A: Pannexin-1 couples to maitotoxin-and nigericininduced interleukin-1beta release through a dye uptake-independent pathway. J Biol Chem 2007;282:2386-2394. (Pubitemid 47076789)
62. Yan Z, Li S, Liang Z, Tomic M, Stojilkovic SS: The P2X7 Receptor Channel Pore Dilates under Physiological Ion Conditions. J Gen Physiol 2008;132:563-573.
63. Pelegrin P, Surprenant A: Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor. Embo J 2006;25:5071-5082. (Pubitemid 44658525)
64. Locovei S, Scemes E, Qiu F, Spray DC, Dahl G: Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex. FEBS Lett 2007;581:483-488. (Pubitemid 46149626)
65. Silverman W, Locovei S, Dahl G: Probenecid, a gout remedy, inhibits pannexin 1 channels. Am J Physiol Cell Physiol 2008;295:C761-767.
66. Iglesias R, Spray DC, Scemes E: Mefloquine blockade of Pannexin1 currents: resolution of a conflict. Cell Commun Adhes 2009;16:131-137.
67. McLaughlin CW, Zellhuber-McMillan S, Macknight AD, Civan MM: Electron Microprobe Analysis of Rabbit Ciliary Epithelium Indicates Enhanced Secretion Posteriorly and Enhanced Absorption Anteriorly. Am J Physiol Cell Physiol 2007;293:C1455-1466. (Pubitemid 350085619)
68. Wang Y, Roman R, Lidofsky SD, Fitz JG: Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc Natl Acad Sci U S A 1996;93:12020-12025. (Pubitemid 26347241)
69. Grygorczyk R, Hanrahan JW: CFTRindependent ATP release from epithelial cells triggered by mechanical stimuli. Am J Physiol 1997;272:C1058-1066.
70. Bao L, Sachs F, Dahl G: Connexins are mechanosensitive. Am J Physiol Cell Physiol 2004;287:C1389-1395. (Pubitemid 39382899)
71. Bunse S, Locovei S, Schmidt M, Qiu F, Zoidl G, Dahl G, Dermietzel R: The potassium channel subunit Kvβ3 interacts with pannexin 1 and attenuates its sensitivity to changes in redox potentials. Febs J 2009;276:6258-6270.
72. Locovei S, Wang J, Dahl G: Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett 2006;580:239-244. (Pubitemid 43005343)
73. North RA: Molecular physiology of P2X receptors. Physiol Rev 2002;82:1013-1067.
74. De Vuyst E, Decrock E, De Bock M, Yamasaki H, Naus CC, Evans WH, Leybaert L: Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor. Mol Biol Cell 2007;18:34-46. (Pubitemid 46066708)
75. Garré JM, Retamal MA, Cassina P, Barbeito L, Bukauskas FF, Sáez JC, Bennett MV, Abudara V: FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels. Proc Natl Acad Sci USA 2010;107:22659-22664
76. Schoner W, Scheiner-Bobis G: Endogenous and exogenous cardiac glycosides and their mechanisms of action. Am J Cardiovasc Drugs 2007;7:173-189. (Pubitemid 47049626)
77. Xie Z, Askari A: Na+/K+-ATPase as a signal transducer. Eur J Biochem 2002;269:2434-2439.